Cargando…

Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments

Breast cancer (BC) is the most common malignancy and the second cause of cancer-specific death in women from high-income countries. Infectious agents are the third most important risk factor for cancer incidence after tobacco and obesity. Dysbiosis emerged as a key player that may influence cancer d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vitorino, Marina, Baptista de Almeida, Susana, Alpuim Costa, Diogo, Faria, Ana, Calhau, Conceição, Azambuja Braga, Sofia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832278/ https://www.ncbi.nlm.nih.gov/pubmed/35155205 http://dx.doi.org/10.3389/fonc.2021.815772

Ejemplares similares

Cancer During Pregnancy: How to Handle the Bioethical Dilemmas?—A Scoping Review With Paradigmatic Cases-Based Analysis
por: Alpuim Costa, Diogo, et al.
Publicado: (2020)

Local Breast Microbiota: A “New” Player on the Block
por: Vitorino, Marina, et al.
Publicado: (2022)

Breast Cancer Survivors and Healthy Women: Could Gut Microbiota Make a Difference?—“BiotaCancerSurvivors”: A Case-Control Study
por: Caleça, Telma, et al.
Publicado: (2023)

Human Microbiota and Breast Cancer—Is There Any Relevant Link?—A Literature Review and New Horizons Toward Personalised Medicine
por: Alpuim Costa, Diogo, et al.
Publicado: (2021)

Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome
por: Vicente, Rodrigo, et al.
Publicado: (2022)

Next-Generation Sequencing in Breast Cancer Management: A Case Report of Genomic Tumour Evolution over Time
por: Batista, Marta Vaz, et al.
Publicado: (2021)

A Potential Link Between Prolonged Cork Exposure and Intestinal-Type Sinonasal Adenocarcinoma – Special Findings of a Retrospective Cohort Analysis
por: Alpuim Costa, Diogo, et al.
Publicado: (2020)

The effectiveness of hyperbaric oxygen therapy for managing radiation-induced proctitis – results of a 10-year retrospective cohort study
por: Moreira Monteiro, António, et al.
Publicado: (2023)

Establishment of a 3D Co-culture With MDA-MB-231 Breast Cancer Cell Line and Patient-Derived Immune Cells for Application in the Development of Immunotherapies
por: Saraiva, Diana P., et al.
Publicado: (2020)

Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis of a Multidisciplinary Approach
por: Alpuim Costa, Diogo, et al.
Publicado: (2017)

Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer
por: Zhang, Hongsheng, et al.
Publicado: (2023)

Gut microbiota modulation accounts for the neuroprotective properties of anthocyanins
por: Marques, Cláudia, et al.
Publicado: (2018)

Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review
por: Alpuim Costa, Diogo, et al.
Publicado: (2023)

Editorial: Microbiota and metabolites in cancer immunotherapy
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Recent Advances in Immunotherapy in Metastatic NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity
por: Lau, Eva, et al.
Publicado: (2016)

Intestinal oxidative state can alter nutrient and drug bioavailability
por: Ana, Faria, et al.
Publicado: (2009)

Flavonoid transport across RBE4 cells: A blood-brain barrier model
por: Faria, Ana, et al.
Publicado: (2010)

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy
por: Ocáriz-Díez, Maitane, et al.
Publicado: (2020)

The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy
por: Liu, Xiangjun, et al.
Publicado: (2021)

Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?
por: Lin, Yan, et al.
Publicado: (2022)

Dietary fungi in cancer immunotherapy: From the perspective of gut microbiota
por: Wei, Yibing, et al.
Publicado: (2023)

Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
por: Xing, Liangliang, et al.
Publicado: (2022)

Exosomes and cancer immunotherapy: A review of recent cancer research
por: Cao, Yue, et al.
Publicado: (2023)

Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy
por: Li, Bolei, et al.
Publicado: (2021)

TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress
por: Shen, Xinyuan, et al.
Publicado: (2022)

Phyto-Immunotherapy, a Complementary Therapeutic Option to Decrease Metastasis and Attack Breast Cancer Stem Cells
por: Fiorentino, Susana, et al.
Publicado: (2020)

Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022)

Editorial: Advancements in immunology and immunotherapy for breast cancer
por: Sugie, Tomoharu, et al.
Publicado: (2022)

Immunotherapy for HER-2 positive breast cancer
por: Yang, Tingting, et al.
Publicado: (2023)

Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review
por: Muscolino, Paola, et al.
Publicado: (2023)

Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances
por: Qin, Hao, et al.
Publicado: (2022)

Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy
por: Xiao, Mingshu, et al.
Publicado: (2022)

A Pilot Study on the Metabolic Impact of Mediterranean Diet in Type 2 Diabetes: Is Gut Microbiota the Key?
por: Ismael, Shámila, et al.
Publicado: (2021)

Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects
por: Li, Jing, et al.
Publicado: (2022)

Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
por: Tolba, Mai F., et al.
Publicado: (2021)

Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy
por: Magbanua, Mark Jesus M., et al.
Publicado: (2022)

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
por: Luo, Chenyi, et al.
Publicado: (2022)

Recent Advances in the Treatment of Breast Cancer
por: Tong, Christy W. S., et al.
Publicado: (2018)

A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis
por: Gil, Gabriel Oliveira Bernardes, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r2ljdia8mi3hqt0nqa14qcgnbd